Switching to everolimus versus continuing tacrolimus in renal transplant recipients: the ERIC study

Trial Profile

Switching to everolimus versus continuing tacrolimus in renal transplant recipients: the ERIC study

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 07 Sep 2011

At a glance

  • Drugs Everolimus (Primary) ; Corticosteroids; Mycophenolate sodium; Tacrolimus
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Acronyms ERIC
  • Most Recent Events

    • 04 May 2011 Results presented at the American Transplant Congress -- 11th Joint Congress of the American Society of Transplant Surgeons and the American Society of Transplantation.
    • 15 Aug 2010 Results presented at the 23rd International Congress of the Transplantation Society 2010.
    • 05 Jul 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top